Explore COVID-19 Articles
Celerion COVID-19 blog articles
The global COVID-19 pandemic has altered the mechanics of nearly every industry. For early phase clinical trials, adapting to this crisis has led to augmented risk mitigation procedures and greater use of innovative technology.
Open for Business: Early Phase Clinical Drug Development during the COVID-19 Pandemic.